Ivermectin

Ivermectin Reactions 1680, p196 - 2 Dec 2017 Variou toxicities: 4 case reports In a retrospective study, an 18-year-old boy developed body pain and general fatigue, a 33-year-old man developed headache, a 25-year-old man developed aching eyes, headache and dizziness and a 28-year-old man developed increased itching and dizziness following treatment with ivermectin [dosage and outcomes not stated]. An 18-year-old boy developed body pain and general fatigue following treatment with ivermectin. The boy, who was an Iraqi refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. The day after ivermectin was started, he presented with body pain and general fatigue. The events were treated symptomatically and no new medical visits were required. A 33-year-old man developed headache following treatment with ivermectin. The man, who was a Syrian refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. The day after ivermectin was started, he presented with headache. The events were treated symptomatically and no new medical visits were required. A 25-year-old man developed aching eyes, headache and dizziness following treatment with ivermectin. The man, who was an Iraqi refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. The day after ivermectin was started, he presented with aching eyes, headache and dizziness. The events were treated symptomatically and no new medical visits were required. A 28-year-old man developed increased itching and dizziness following treatment with ivermectin. The man, who was an Afghan refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. He had pre-existing itching for 3.5 weeks. The day after ivermectin was started, he presented with increased itching and dizziness. The events were treated symptomatically and no new medical visits were required. Author comment: Headache, dizziness, increased itching and abnormal sensations in the eye are described in the summary of product characteristics as a side effect of ivermectin. Typical [ivermectin] side effects: Itching, gastrointestinal symptoms, dizziness, headaches, allergies, swollen lymph nodes, fever, headache and muscle pain, low blood pressure. Solbach P, et al. Mass therapy with ivermectin for scabies outbreak during the refugee crisis in Germany in 2015. [German]. Anasthesiologie and Intensivmedizin 58: 534-541, No. 10, Oct 2017. Available from: URL: http://doi.org/10.19224/ ai2017.534 [German; summarised from a translation] - Germany 803284281 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Ivermectin

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/ivermectin-UKrFgv2H9p
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39127-7
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p196 - 2 Dec 2017 Variou toxicities: 4 case reports In a retrospective study, an 18-year-old boy developed body pain and general fatigue, a 33-year-old man developed headache, a 25-year-old man developed aching eyes, headache and dizziness and a 28-year-old man developed increased itching and dizziness following treatment with ivermectin [dosage and outcomes not stated]. An 18-year-old boy developed body pain and general fatigue following treatment with ivermectin. The boy, who was an Iraqi refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. The day after ivermectin was started, he presented with body pain and general fatigue. The events were treated symptomatically and no new medical visits were required. A 33-year-old man developed headache following treatment with ivermectin. The man, who was a Syrian refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. The day after ivermectin was started, he presented with headache. The events were treated symptomatically and no new medical visits were required. A 25-year-old man developed aching eyes, headache and dizziness following treatment with ivermectin. The man, who was an Iraqi refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. The day after ivermectin was started, he presented with aching eyes, headache and dizziness. The events were treated symptomatically and no new medical visits were required. A 28-year-old man developed increased itching and dizziness following treatment with ivermectin. The man, who was an Afghan refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. He had pre-existing itching for 3.5 weeks. The day after ivermectin was started, he presented with increased itching and dizziness. The events were treated symptomatically and no new medical visits were required. Author comment: Headache, dizziness, increased itching and abnormal sensations in the eye are described in the summary of product characteristics as a side effect of ivermectin. Typical [ivermectin] side effects: Itching, gastrointestinal symptoms, dizziness, headaches, allergies, swollen lymph nodes, fever, headache and muscle pain, low blood pressure. Solbach P, et al. Mass therapy with ivermectin for scabies outbreak during the refugee crisis in Germany in 2015. [German]. Anasthesiologie and Intensivmedizin 58: 534-541, No. 10, Oct 2017. Available from: URL: http://doi.org/10.19224/ ai2017.534 [German; summarised from a translation] - Germany 803284281 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off